EGFR and cancer: A randomised controlled phase III trial of 80 cancer patients treated with EGFR inhibitors showed that the application of EGF ointment twice daily significantly improved skin toxicities (77.8% response rate using 20 ppm EGF concentration) and patient quality of life [52].